Peterfy, C., Dicarlo, J., Emery, P., Genovese, M., Keystone, E., Taylor, P., . . . Macias, W. (2019). Use of magnetic resonance imaging to support dose selection in a phase II trial of baricitinib combined with conventional synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis. Journal of Rheumatology.
Trích dẫn kiểu Chicago (xuất bản lần thứ 7)Peterfy, C., et al. Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of Rheumatology, 2019.
Trích dẫn kiểu MLA (xuất bản lần thứ 9)Peterfy, C., et al. Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of Rheumatology, 2019.